<unk> , sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). For multiple myeloma, it is used after at least one other treatment and generally with dexamethasone. It is taken by mouth. Common side effects include diarrhea, itchiness, joint pain, fever, headache, and trouble sleeping. Severe side effects include low blood platelets, low white blood cells, and blood clots. Use during pregnancy may harm the fetus. The dose may need to be adjusted in people with kidney problems. It has a chemical structure similar to thalidomide but has a different mechanism of action. How it works is not entirely clear as of 2019.<unk>  was approved for medical use in the United States in 2005. It is on the World Health Organization's List of Essential Medicines.
Lenalidomide
Ruxolitinib
Pomalidomide
Vincristine
Bortezomib
Rituximab
Ibrutinib
Alemtuzumab